platinum and other heavy metal compo...
| |
platinum and other heavy metal compounds in cancer chemotherapy
|
nitric oxide (no) and cancer
| |
nitric oxide (no) and cancer
|
antiangiogenic agents in cancer ther...
| |
antiangiogenic agents in cancer therapy /
|
telomeres and telomerase in cancer
| |
telomeres and telomerase in cancer
|
supportive care in cancer therapy
| |
supportive care in cancer therapy
|
|
|
natural killer t cells
|
tumor models in cancer research
| |
tumor models in cancer research
|
hormone therapy in breast and prosta...
| |
hormone therapy in breast and prostate cancer
|
|
|
stem cells and cancer
|
protein tyrosine kinases :
| |
protein tyrosine kinases :
|
pi3k-mtor in cancer and cancer therapy
| |
pi3k-mtor in cancer and cancer therapy
|
|
|
cancer chemoprevention.
|
sensitization of cancer cells for ch...
| |
sensitization of cancer cells for chemo/immuno/radio-therapy
|
cell cycle inhibitors in cancer ther...
| |
cell cycle inhibitors in cancer therapy :
|
death receptors in cancer therapy
| |
death receptors in cancer therapy
|
|
|
oncogenomics handbook
|
|
|
cancer drug resistance /
|
apoptosis, senescence, and cancer /
| |
apoptosis, senescence, and cancer /
|
checkpoint responses in cancer therapy
| |
checkpoint responses in cancer therapy
|
parp inhibitors for cancer therapy
| |
parp inhibitors for cancer therapy
|